Biomaterials Market Research That Multiply your Investment!

In a latest research report published by Transparency Market Research (TMR) “Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global biomaterials market is forecasted to grow at a CAGR of 4.1% between 2013 and 2019. According to the report, the market is estimated to be valued at US$33,600 million by 2019, increasing from US$25,277.8 million in 2012. Biomaterials are fabricated from either synthetic or natural origin materials that are used for medical implants. Heart valves, dental implants, artificial hip joints, and intraocular lenses are some of the commonly used medical implants for which biocompabitility and safety needs to be guaranteed, since these implants come in close proximity to internal organs in the human body. Owing to such reasons it necessary that biomaterials are biocompatible, which means they should not interfere with the physiology and not cause any immunogenic reaction in the human body.

Growth Drivers and Opportunities 

According to the findings of this market research report, the biomaterials market for implantable

devices will find a remunerative consumer base in the aging population that is pushing up the demand for graft transplants and medical implants. The average life expectancy of humans is on the rise, and continues to increase in densely populated emerging countries. 

A growing incidence of diseases such as osteoporosis and arthritis will continue to propel the need for medical implants, which in turn utilize biomaterials. The focus remains on making implants and related procedures as comfortable and painless as possible among patients. 

Overview of segments and their growth prospects 

The report finds that as of 2012, metals as a biomaterial for implantable devices constituted the largest share within the global biomaterials market. The polymer biomaterials segment came a close second and continues to exhibit promising growth. TMR analysts predict that the polymers segment will witness the fastest growth within the biomaterials market for implantable devices between 2013 and 2019. 

According to the report, as of 2012, orthopedic applications were seen to hold a considerable share in the global biomaterials market for implantable devices because of a high number of knee and hip replacement procedures. In the near future, the biopolymers segment will receive impetus from the ophthalmic applications.

The report also finds that countries such as United States, Germany, Canada, France, Italy, U.K., and Spain are recording a high number of medical implant procedures, whereas the same remain sluggish in other regions. North America is the largest biomaterials market for implantable devices with Europe taking the second place globally. But the competition here remains cutthroat and this has prompted many players to venture into hitherto untapped markets in the Asia-Pacific region, such as Japan, China, South Korea, India, and Taiwan.

Request a Custom Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2384

Companies mentioned in the biomaterials market for implantable devices study

The report profiles prominent names in the global biomaterials market for implantable devices, such as: AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Collagen Matrix, Inc., Ceradyne, Inc., DuPont, Evonik Industries AG, Royal DSM, Corbion Purac, and Invibio, Inc.